Illumina Stock News

The company's liquid-biopsy spinoff can reportedly detect early-stage cancer in blood samples.

These stocks could bring some heat to your portfolio.

Is (ILMN) Outperforming Other Medical Stocks This Year?

Illumina (ILMN) derives benefits from the cascading effect of the ACOG guidance on increasing coverage of NIPT for all pregnancies.

Baillie Gifford's Tom Slater invests in companies and CEOs with long-term vision, irrespective of short-term market moves.

Cathie Wood lost her conviction and dumped the stock. Can Illumina get back on track?

Illumina, Inc. (ILMN) Francis deSouza Presents at Goldman Sachs 42nd Annual Global Healthcare Conference (Transcript)

It'll cover a lot of ground in the next 14 years.

These healthcare stocks are at the forefront of huge trends, including precision medicine and advances in diagnosis technologies. The post 5 Healthcare Stocks to Buy for Their Game-Changing Potential

Are you looking for stocks that have been beaten up in recent weeks? Here are seven stocks to buy right now at the start of the summer.

Twenty years after the human genome was sequenced, a new wave of discovery has begun.

Illumina's (ILMN) VeriSeq NIPT Solution v2 provides accurate, consistent and scalable end-to-end genome-wide noninvasive prenatal testing.

SAN DIEGO--(BUSINESS WIRE)--Illumina and BeSolveRD will study the clinical utility and health economic impact of WGS of patients with intellectual disabilities.

MELBOURNE, Australia--(BUSINESS WIRE)--Illumina and Next Generation Genomic Co. announced launch of VeriSeq™ NIPT Solution v2 in Thailand, a CE-IVD, NGS-based approach to NIPT.

SAN DIEGO--(BUSINESS WIRE)---- $ILMN #ILMN--Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference: Goldman Sachs 42nd Annual Global He